Your choice of syringe size depends on how much BAC water for 10mg Retatrutide you used during reconstitution
(2025, Nature Metabolism ) reported daLUXendin and daLUXendin+, non-lipidated and lipidated dual GLP-1/GIP receptor agonist fluorescent probes with nanomolar affinity at both hGLP1R and hGIPR
Tirzepatide (Mounjaro) (Note: Technically a dual GLP-1/GIP agonist) Approved for diabetes, with weight loss benefits under clinical evaluation for obesity
Retatrutide reported up to 28.7% average weight loss and pain reduction of up to 75.8% on the WOMAC scale in adults with obesity and knee osteoarthritis [9]
This article examines the mechanism, benefits, and considerations associated with oral tirzepatide, offering a comprehensive overview for individuals interested in contemporary diabetes management
Always follow the instructions on OTC products and do a patch test to avoid any bad reactions